{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:50:44Z","timestamp":1773409844629,"version":"3.50.1"},"reference-count":13,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:00:00Z","timestamp":1346112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl J Gynecology &amp; Obste"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To explore 400\u2010\u03bcg sublingual misoprostol as primary treatment in lower\u2010level facilities with no previous experience providing postabortion care.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Women presenting with incomplete abortion were offered a single dose of 400\u2010\u03bcg sublingual misoprostol. Incomplete abortion was defined as uterine size consistent with fewer than 12 weeks of gestation, open cervical os, and reports of past or present history of vaginal bleeding. Women returned to the clinic 1 week after misoprostol administration for follow\u2010up. At that time, they were discharged if the uterine evacuation was a success or were offered a second follow\u2010up visit or surgical completion if still incomplete.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>One\u2010hundred women received misoprostol; outcome data were unavailable for 1 woman. Complete uterine evacuation was achieved for 97 (98.0%) women. Satisfaction was high, with nearly all women indicating that they were \u201csatisfied\u201d (n = 57 [57.6%]) or \u201cvery satisfied\u201d (n = 41 [41.4%]) with their experience. Adverse effects were considered \u201ctolerable\u201d by 72 of 97 (74.2%) women. Ninety\u2010seven of 99 (98.0%) participants indicated that they would choose misoprostol for incomplete abortion care in the future and 95 of 97 (97.9%) stated that they would recommend it to a friend.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Misoprostol is a viable option for treatment of incomplete abortion at mid\u2010level facilities.<\/jats:p><jats:p><jats:bold>Clinical<\/jats:bold> <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/trials.gov\">trials.gov<\/jats:ext-link>: <jats:bold>NCT00466999<\/jats:bold>.<\/jats:p><\/jats:sec>","DOI":"10.1016\/j.ijgo.2012.05.036","type":"journal-article","created":{"date-parts":[[2012,8,28]],"date-time":"2012-08-28T00:30:30Z","timestamp":1346113830000},"page":"166-169","source":"Crossref","is-referenced-by-count":12,"title":["Oral misoprostol as first\u2010line care for incomplete abortion in Burkina Faso"],"prefix":"10.1002","volume":"119","author":[{"given":"Thieba","family":"Blandine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adama Z.","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Coral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cisse","family":"Hassane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hien","family":"Clotaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blami","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Lankoande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayisha","family":"Diop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Blum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,28]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1586\/17474108.2.1.67"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.09.009"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01469.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.05.003"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.08.022"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2007.01468.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2008.11.016"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2010.06.021"},{"key":"e_1_2_6_10_2","unstructured":"World Health Organization.Unedited Draft Report of the 17th Expert Committee on the Selection and Use of Essential Medicines.http:\/\/www.sld.cu\/galerias\/pdf\/servicios\/medicamentos\/17th_who_model_list_of_essential_medicines _april_2009.pdf. Published April 30 2009. Accessed October 30 2011"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dei163"},{"issue":"4","key":"e_1_2_6_12_2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/deh709","article-title":"Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management","volume":"20","author":"Graziosi G.C.","year":"2005","journal-title":"Hum Reprod"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1363\/3704011"},{"key":"e_1_2_6_14_2","author":"FIGO \u2010 MISOPROSTOL","year":"2012","journal-title":"\u2010 Recommended Dosages"}],"updated-by":[{"DOI":"10.1016\/j.ijgo.2012.12.004","type":"err","label":"Erratum","source":"publisher","updated":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000}}],"container-title":["International Journal of Gynecology &amp; Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729212003736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0020729212003736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2012.05.036","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1016%2Fj.ijgo.2012.05.036","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1016\/j.ijgo.2012.05.036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T06:34:04Z","timestamp":1696487644000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1016\/j.ijgo.2012.05.036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,28]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1016\/j.ijgo.2012.05.036"],"URL":"https:\/\/doi.org\/10.1016\/j.ijgo.2012.05.036","archive":["Portico"],"relation":{"err":[{"id-type":"doi","id":"10.1016\/j.ijgo.2012.12.004","asserted-by":"object"}]},"ISSN":["0020-7292","1879-3479"],"issn-type":[{"value":"0020-7292","type":"print"},{"value":"1879-3479","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,28]]}}}